SCHEMBL4085912

SCHEMBL4085912

CN(C)c1ccc2c(N)cccc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
CYP3A4 P08684 4/20 0.48
TSHR P16473 4/20 0.48
HPGD P15428 3/20 0.48
HSD17B10 Q99714 3/20 0.48
KEAP1 Q14145 1/20 0.48
KDM4E B2RXH2 3/20 0.43
LMNA P02545 2/20 0.43
NPC1 O15118 1/20 0.43
GLA P06280 1/20 0.43
POLB P06746 1/20 0.43
GAA P10253 1/20 0.43
PTBP1 P26599 1/20 0.43
RAB9A P51151 1/20 0.43
KMT2A Q03164 1/20 0.43
RCE1 Q9Y256 1/20 0.43
APAF1 O14727 1/20 0.41
TDP1 Q9NUW8 2/20 0.40
ALOX15 P16050 2/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4076470 0.85 F2 (0.49) ALDH1A1CYP3A4TSHRHPGDHSD17B10
SCHEMBL12748865 0.78 CYP1A2 (0.59) ALDH1A1CYP3A4TSHRHPGDHSD17B10
SCHEMBL2025062 0.78 MCL1 (0.50) ALDH1A1TSHRHSD17B10KDM4ELMNA
SCHEMBL4078320 0.78 ALDH1A1 (0.45) ALDH1A1CYP3A4TSHRHPGDHSD17B10
SCHEMBL13845106 0.78 ALDH1A1 (0.50) ALDH1A1CYP3A4TSHRHPGDHSD17B10
SCHEMBL10082319 0.77 KDM4E (0.54) ALDH1A1TSHRHPGDHSD17B10KDM4E
SCHEMBL26381937 0.77 ALDH1A1 (0.39) ALDH1A1CYP3A4TSHRHSD17B10KDM4E
SCHEMBL22538140 0.76 ALDH1A1 (0.54) ALDH1A1TSHRHPGDHSD17B10KDM4E
SCHEMBL12260007 0.74 APP (0.54) ALDH1A1CYP3A4TSHRHPGDHSD17B10
SCHEMBL12277638 0.74 APP (0.54) ALDH1A1CYP3A4TSHRHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7482339-B2 2-Naphthylimino-1,3-thiazine derivative SHIONOGI AND CO., LTD. (JP) 2009-01-27 US disclosed
US-20060281738-A1 2-Naphthylimino-1,3-thiazine derivative SHIONOGI AND CO., LTD. (JP) 2006-12-14 US disclosed
EP-1659117-A1 2-NAPHTHYLIMINO-1,3-THIAZINE DERIVATIVE SHIONOGI & CO., LTD. (JP) 2006-05-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060281738-A1 2-Naphthylimino-1,3-thiazine derivative NPM1, OXTR, CYP2S1 ALDH1A1 1571/4885CYP3A4 95/4885TSHR 440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.